Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

Articles published in
Science
    March 2024
  1. MICHEL AL
    Vaccines to control tuberculosis in cattle.
    Science. 2024;383:1410-1411.
    >> Share

  2. FROMSA A, Willgert K, Srinivasan S, Mekonnen G, et al
    BCG vaccination reduces bovine tuberculosis transmission, improving prospects for elimination.
    Science. 2024;383:eadl3962.
    >> Share

  3. TRIUNFOL M
    Brazil is hoping and waiting for a new vaccine as dengue rages.
    Science. 2024;383:1042-1043.
    >> Share

  4. COHEN J
    Skin side effects stymie advance of HIV vaccine.
    Science. 2024;383:1044.
    >> Share

  5. PAWAR P
    World's cholera vaccine stash is empty-but relief is on its way.
    Science. 2024;383:939-940.
    >> Share

    December 2023
  6. MIGUELES SA, Nettere DM, Gavil NV, Wang LT, et al
    HIV vaccines induce CD8(+) T cells with low antigen receptor sensitivity.
    Science. 2023;382:1270-1276.
    >> Share

    November 2023
  7. COHEN J
    A chikungunya vaccine is likely to get approved. Who will get it?
    Science. 2023;382:503-504.
    >> Share

    October 2023
  8. WADMAN M
    First malaria vaccine slashes childhood deaths.
    Science. 2023;382:357.
    >> Share

  9. COHEN J
    Billions boost next-generation weapons against SARS-CoV-2.
    Science. 2023;382:359-360.
    >> Share

  10. KRAMMER F, Ellebedy AH
    Variant-adapted COVID-19 booster vaccines.
    Science. 2023;382:157-159.
    >> Share

  11. COUZIN-FRANKEL J
    New Novavax vaccine OK'd; studies size it up against mRNA.
    Science. 2023;382:141-142.
    >> Share

  12. VOGEL G
    Second malaria vaccine gets WHO green light.
    Science. 2023;382:16-17.
    >> Share

  13. OFFORD C, Cohen J
    Award honors pair for mRNA work key to COVID-19 vaccines.
    Science. 2023;382:22.
    >> Share

    September 2023
  14. GOLDMAN MA
    Pandemics and their lessonsForeign Bodies: Pandemics, Vaccines, and the Health of Nations Simon Schama Ecco, 2023. 480 pp.
    Science. 2023;381:1418.
    >> Share

    July 2023
  15. COHEN J
    Childhood vaccine crusader shares concerns for future.
    Science. 2023;381:365.
    >> Share

  16. VOGEL G, Couzin-Frankel J
    Studies probe COVID-19 shots' link to rare symptoms.
    Science. 2023;381:18-19.
    >> Share

    June 2023
  17. COHEN J
    Companies hoard COVID-19 vaccines, stalling future research.
    Science. 2023;380:1001-1002.
    >> Share

    May 2023
  18. COUZIN-FRANKEL J
    Decision nears for fall coronavirus vaccine.
    Science. 2023;380:784.
    >> Share

  19. LAVERY JV, Porter RM, Addiss DG
    Cascading failures in COVID-19 vaccine equity.
    Science. 2023;380:460-462.
    >> Share

    April 2023
  20. KAISER J
    Tailored melanoma vaccine may stave off cancer.
    Science. 2023;380:232.
    >> Share

  21. OFFERSGAARD A, Bukh J, Gottwein JM
    Toward a vaccine against hepatitis C virus.
    Science. 2023;380:37-38.
    >> Share

    March 2023
  22. CHUBATSU NUNES HH, Dang TT
    A booster for vaccines from plants.
    Science. 2023;379:1187-1188.
    >> Share

  23. VOGEL G
    Do COVID-19 vaccine mandates still make sense?
    Science. 2023;379:1072-1073.
    >> Share

    February 2023
  24. NORMILE D
    Japan moves to bolster its vaccine R&D sector.
    Science. 2023;379:627.
    >> Share

  25. COUZIN-FRANKEL J
    New COVID-19 vaccine strategy would mimic flu's annual shots.
    Science. 2023;379:425-426.
    >> Share

    January 2023
  26. KALIA A, Hickman HD
    A vaccine sanctuary in the lymph node.
    Science. 2023;379:332-333.
    >> Share

    December 2022
  27. VOGEL G
    Pandemic vaccine equity plan may soon start winding down.
    Science. 2022;378:1158-1159.
    >> Share

  28. MOORE PL
    Triggering rare HIV antibodies by vaccination.
    Science. 2022;378:949-950.
    >> Share

  29. LEGGAT DJ, Cohen KW, Willis JR, Fulp WJ, et al
    Vaccination induces HIV broadly neutralizing antibody precursors in humans.
    Science. 2022;378:eadd6502.
    >> Share

  30. KUPFERSCHMIDT K
    Vaccines are in short supply amid global cholera surge.
    Science. 2022;378:938-939.
    >> Share

    November 2022
  31. KELVIN AA, Falzarano D
    The influenza universe in an mRNA vaccine.
    Science. 2022;378:827-828.
    >> Share

  32. AREVALO CP, Bolton MJ, Le Sage V, Ye N, et al
    A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.
    Science. 2022;378:899-904.
    >> Share

  33. MALE V
    COVID-19 vaccination and menstruation.
    Science. 2022;378:704-706.
    >> Share

    October 2022
  34. COHEN J
    Forgotten Ebola vaccine could help in outbreak.
    Science. 2022;378:340-341.
    >> Share

  35. MAO T, Israelow B, Pena-Hernandez MA, Suberi A, et al
    Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses.
    Science. 2022 Oct 27:eabo2523. doi: 10.1126/science.abo2523.
    >> Share

  36. TORRENTS DE LA PENA A, Sliepen K, Eshun-Wilson L, Newby ML, et al
    Structure of the hepatitis C virus E1E2 glycoprotein complex.
    Science. 2022;378:263-269.
    >> Share

  37. COUZIN-FRANKEL J
    Heart risks fuel debate over COVID-19 boosters.
    Science. 2022;378:234-235.
    >> Share

  38. COHEN J
    Uganda's Ebola outbreak will put novel vaccines to the test.
    Science. 2022;378:14-15.
    >> Share

    September 2022
  39. VOGEL G
    New Omicron strains may portend big COVID-19 waves.
    Science. 2022;377:1479.
    >> Share

    August 2022
  40. WHERRY EJ, Barouch DH
    T cell immunity to COVID-19 vaccines.
    Science. 2022;377:821-822.
    >> Share

  41. KUPFERSCHMIDT K
    Scientists scramble to set up monkeypox vaccine trials.
    Science. 2022;377:696-697.
    >> Share

  42. COHEN J
    Making broader coronavirus vaccines is a struggle.
    Science. 2022;377:566-567.
    >> Share

    July 2022
  43. DOLGIN E
    The ascent of ModernaThe Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World Peter Loftus Harvard Business Review Press, 2022. 320 pp.
    Science. 2022;377:479.
    >> Share

  44. BOWEN JE, Addetia A, Dang HV, Stewart C, et al
    Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.
    Science. 2022 Jul 19:eabq0203. doi: 10.1126/science.abq0203.
    >> Share

  45. CHEN R, Guo X, Zhu A
    Vaccinate to combat COVID-19 in China.
    Science. 2022;377:271.
    >> Share

  46. DACON C, Tucker C, Peng L, Lee CD, et al
    Broadly neutralizing antibodies target the coronavirus fusion peptide.
    Science. 2022 Jul 12:eabq3773. doi: 10.1126/science.abq3773.
    >> Share

    June 2022
  47. REYNOLDS CJ, Pade C, Gibbons JM, Otter AD, et al
    Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure.
    Science. 2022 Jun 14:eabq1841. doi: 10.1126/science.abq1841.
    >> Share

  48. KUPFERSCHMIDT K
    Monkeypox vaccination plans take shape amid questions.
    Science. 2022;376:1142-1143.
    >> Share

    May 2022
  49. STOKSTAD E
    Wrestling with bird flu, Europe considers once-taboo vaccines.
    Science. 2022;376:682-683.
    >> Share

  50. DOLGIN E
    Better lipids to power next generation of mRNA vaccines.
    Science. 2022;376:680-681.
    >> Share

  51. VOGEL G
    New subvariants are masters of immune evasion.
    Science. 2022;376:679-680.
    >> Share

    April 2022
  52. COHEN J
    First self-copying mRNA vaccine proves itself in pandemic trial.
    Science. 2022;376:446.
    >> Share

  53. PULLA P
    India's speedy vaccine approvals come under fire.
    Science. 2022;376:442-443.
    >> Share

  54. ARINAMINPATHY N, Saad-Roy CM, Yang Q, Ahmad I, et al
    A global system for the next generation of vaccines.
    Science. 2022;376:462-464.
    >> Share

  55. COUZIN-FRANKEL J
    Global project gears up to study vaccine safety.
    Science. 2022;376:227-228.
    >> Share

  56. COHEN J
    New crop of mRNA vaccines aim for accessibility.
    Science. 2022;376:120-121.
    >> Share

  57. NORMILE D
    Japan reboots HPV vaccination drive after 9-year gap.
    Science. 2022;376:14.
    >> Share

    March 2022
  58. LENTZOS F, Rybicki EP, Engelhard M, Paterson P, et al
    Self-spreading vaccines: Base policy on evidence-Response.
    Science. 2022;375:1363.
    >> Share

  59. STREICKER DG, Bull JJ, Nuismer SL
    Self-spreading vaccines: Base policy on evidence.
    Science. 2022;375:1362-1363.
    >> Share

  60. DEAN NE, Halloran ME
    Protecting the herd with vaccination.
    Science. 2022;375:1088-1089.
    >> Share

  61. ALTMANN DM, Boyton RJ
    COVID-19 vaccination: The road ahead.
    Science. 2022;375:1127-1132.
    >> Share

  62. EDWARDS AM, Baric RS, Saphire EO, Ulmer JB, et al
    Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Science. 2022;375:1133-1139.
    >> Share

  63. KOELLE K, Martin MA, Antia R, Lopman B, et al
    The changing epidemiology of SARS-CoV-2.
    Science. 2022;375:1116-1121.
    >> Share

  64. MOBARAK AM, Miguel E, Abaluck J, Ahuja A, et al
    End COVID-19 in low- and middle-income countries.
    Science. 2022;375:1105-1110.
    >> Share

  65. ROBERTS L
    Africa battles out-of-control polio outbreaks.
    Science. 2022;375:1079-1080.
    >> Share

    February 2022
  66. BIERING SB
    One antibody to treat them all.
    Science. 2022;375:803.
    >> Share

  67. ROURKE M, Eccleston-Turner M, Switzer S
    Sovereignty, sanctions, and data sharing under international law.
    Science. 2022;375:724-726.
    >> Share

  68. KAKU CI, Champney ER, Normark J, Garcia M, et al
    Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination.
    Science. 2022 Feb 10:eabn2688. doi: 10.1126/science.abn2688.
    >> Share

  69. ELLIOTT P, Bodinier B, Eales O, Wang H, et al
    Rapid increase in Omicron infections in England during December 2021: REACT-1 study.
    Science. 2022 Feb 8:eabn8347. doi: 10.1126/science.abn8347.
    >> Share

  70. WADMAN M
    New Omicron begins to take over, despite late start.
    Science. 2022;375:480-481.
    >> Share

    January 2022
  71. COUZIN-FRANKEL J, Vogel G
    Vaccines may cause rare, Long Covid-like symptoms.
    Science. 2022;375:364-366.
    >> Share

  72. KUPFERSCHMIDT K
    After Omicron, some scientists foresee 'a period of quiet'.
    Science. 2022;375:366-367.
    >> Share

  73. HAYEK S, Shaham G, Ben-Shlomo Y, Kepten E, et al
    Indirect protection of children from SARS-CoV-2 infection through parental vaccination.
    Science. 2022 Jan 27:eabm3087. doi: 10.1126/science.abm3087.
    >> Share

  74. PRUNAS O, Warren JL, Crawford FW, Gazit S, et al
    Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel.
    Science. 2022 Jan 27:eabl4292. doi: 10.1126/science.abl4292.
    >> Share

  75. WADMAN M
    Studies reveal dangers of SARS-CoV-2 infection in pregnancy.
    Science. 2022;375:253.
    >> Share

  76. MANNAR D, Saville JW, Zhu X, Srivastava SS, et al
    SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex.
    Science. 2022 Jan 20:eabn7760. doi: 10.1126/science.abn7760.
    >> Share

  77. MUIK A, Lui BG, Wallisch AK, Bacher M, et al
    Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.
    Science. 2022 Jan 18:eabn7591. doi: 10.1126/science.abn7591.
    >> Share

  78. KAISER J
    Study of soldiers implicates common virus as MS trigger.
    Science. 2022;375:133.
    >> Share

  79. OPENSHAW PJM
    Using correlates to accelerate vaccinology.
    Science. 2022;375:22-23.
    >> Share

  80. LENTZOS F, Rybicki EP, Engelhard M, Paterson P, et al
    Eroding norms over release of self-spreading viruses.
    Science. 2022;375:31-33.
    >> Share

  81. KUPFERSCHMIDT K, Vogel G
    Omicron threat remains fuzzy as cases explode.
    Science. 2022;375:9-10.
    >> Share

    December 2021
  82. GUPTA RK, Topol EJ
    COVID-19 vaccine breakthrough infections.
    Science. 2021;374:1561-1562.
    >> Share

  83. COHEN J
    Will global vaccine shortfalls end in 2022?
    Science. 2021;374:1546.
    >> Share

  84. COHEN J
    Omicron sparks a vaccine strategy debate.
    Science. 2021;374:1544-1545.
    >> Share

  85. VOGEL G, Kupferschmidt K
    Early lab studies shed light on Omicron's behavior.
    Science. 2021;374:1543-1544.
    >> Share

  86. CERNUSCHI T, Malvolti S, Downham M, Maugeais D, et al
    COVID-19 impact on infant and adolescent vaccine supplies.
    Science. 2021;374:1438-1441.
    >> Share

  87. KUPFERSCHMIDT K
    Missed shots.
    Science. 2021;374:1434-1435.
    >> Share

  88. KUPFERSCHMIDT K
    Scientists see a 'really, really tough winter' with Omicron.
    Science. 2021;374:1421-1422.
    >> Share

  89. KUPFERSCHMIDT K, Vogel G
    How bad is Omicron? Some clues are emerging.
    Science. 2021;374:1304-1305.
    >> Share

  90. KUPFERSCHMIDT K
    Where did 'weird' Omicron come from?
    Science. 2021;374:1179.
    >> Share

  91. REYNOLDS CJ, Gibbons JM, Pade C, Lin KM, et al
    Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.
    Science. 2021 Dec 2:eabm0811.
    >> Share

  92. NABEL KG, Clark SA, Shankar S, Pan J, et al
    Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.
    Science. 2021 Dec 2:eabl6251.
    >> Share

    November 2021
  93. GILBERT PB, Montefiori DC, McDermott AB, Fong Y, et al
    Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
    Science. 2021 Nov 23:eab3435.
    >> Share

  94. WADMAN M
    To fight Lyme disease, vaccine targets ticks.
    Science. 2021;374:925.
    >> Share

  95. GERBER JS, Offit PA
    COVID-19 vaccines for children.
    Science. 2021;374:913.
    >> Share

  96. NORMILE D
    'Zero COVID' is getting harder-but China is sticking with it.
    Science. 2021;374:924.
    >> Share

  97. JECKER NS
    Cash incentives, ethics, and COVID-19 vaccination.
    Science. 2021;374:819-820.
    >> Share

  98. MCCALLUM M, Walls AC, Sprouse KR, Bowen JE, et al
    Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants.
    Science. 2021 Nov 9:eabl8506. doi: 10.1126/science.abl8506.
    >> Share

  99. LADHANI SN
    Children and COVID-19 in schools.
    Science. 2021;374:680-682.
    >> Share

  100. COHN BA, Cirillo PM, Murphy CC, Krigbaum NY, et al
    SARS-CoV-2 vaccine protection and deaths among US veterans during 2021.
    Science. 2021 Nov 4:eabm0620. doi: 10.1126/science.abm0620.
    >> Share

  101. ELLIOTT P, Haw D, Wang H, Eales O, et al
    Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.
    Science. 2021 Nov 2:eabl9551. doi: 10.1126/science.abl9551.
    >> Share

    October 2021
  102. KRISHTEL P, Hassan F
    Share vaccine know-how.
    Science. 2021;374:379.
    >> Share

  103. ROBERTS L
    Polio vaccination to resume across Afghanistan.
    Science. 2021;374:382.
    >> Share

  104. CORBETT KS, Gagne M, Wagner DA, O' Connell S, et al
    Protection against SARS-CoV-2 beta variant in mRNA-1273 vaccine-boosted nonhuman primates.
    Science. 2021 Oct 21:eabl8912. doi: 10.1126/science.abl8912.
    >> Share

  105. VOGEL G
    WHO gives first malaria vaccine the green light.
    Science. 2021;374:245-246.
    >> Share

  106. GOEL RR, Painter MM, Apostolidis SA, Mathew D, et al
    mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.
    Science. 2021 Oct 14:eabm0829. doi: 10.1126/science.abm0829.
    >> Share

  107. CAMPOS-MERCADE P, Meier AN, Schneider FH, Meier S, et al
    Monetary incentives increase COVID-19 vaccinations.
    Science. 2021 Oct 7:eabm0475. doi: 10.1126/science.abm0475.
    >> Share

  108. COHEN J
    New Chinese vaccine could bolster global arsenal.
    Science. 2021;374:12-13.
    >> Share

    September 2021
  109. WADMAN M
    Israel's high case plateau may offer worrisome portent.
    Science. 2021;373:1428-1429.
    >> Share

  110. WADMAN M
    SARS-CoV-2 infection confers greater immunity than shots.
    Science. 2021;373:1067-1068.
    >> Share

    August 2021
  111. PINTO D, Sauer MM, Czudnochowski N, Low JS, et al
    Broad betacoronavirus neutralization by a stem helix-specific human antibody.
    Science. 2021 Aug 3. pii: science.abj3321. doi: 10.1126/science.abj3321.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016